Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Gene Ther. 2010 May 27;17(7):922–929. doi: 10.1038/gt.2010.82

Figure 4.

Figure 4

Effect of Bevacizumab/oHSV combination therapy on animal survival. Mice bearing A673 xenograft tumors 250-500 mm3 were given one or the other treatment or control on days 0 and 3 (arrows). Survival of animals was monitored and is shown as days post the first injection.